RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Revolution Medicines Stock

Revolution Medicines ROCE 2025

Revolution Medicines ROCE

-0.3

Ticker

RVMD

ISIN

US76155X1000

WKN

A2PYWG

In 2025, Revolution Medicines's return on capital employed (ROCE) was -0.3, a 14.1% increase from the -0.27 ROCE in the previous year.

Revolution Medicines Aktienanalyse

What does Revolution Medicines do?

Revolution Medicines Inc is a biotechnology company specializing in the development of cancer medications. It was founded in 2014 in Redwood City, California. The company has received significant investment amounts in recent years and is focused on researching and developing personalized cancer therapies that act on a molecular level. They employ a new method called "in-situ imaging" for faster and more precise identification of treatment options. Revolution Medicines is divided into various areas including research and development of new drugs, collaboration with external partners, and conducting their own testing procedures. Their products include a variety of tailored cancer therapies, with RMC-4630 being one of their most promising therapies for advanced breast cancer. They have more products in development and aim to expand their development opportunities through partnerships with other companies in the cancer research field. This company aims to revolutionize cancer research by developing targeted therapies customized to meet individual patient needs, utilizing innovative methods and technologies. However, they face challenges in understanding and treating the complexity of molecular processes in cancer cells, as well as competition in the field. Overall, Revolution Medicines is a biotechnology company focused on shaping the future of cancer research. Revolution Medicines ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Revolution Medicines's Return on Capital Employed (ROCE)

Revolution Medicines's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Revolution Medicines's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Revolution Medicines's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Revolution Medicines’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Revolution Medicines stock

What is the ROCE (Return on Capital Employed) of Revolution Medicines this year?

The ROCE of Revolution Medicines is -0.3 undefined this year.

How has the ROCE (Return on Capital Employed) of Revolution Medicines developed compared to the previous year?

The ROCE of Revolution Medicines has increased by 14.1% increased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Revolution Medicines?

A high Return on Capital Employed (ROCE) indicates that Revolution Medicines has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Revolution Medicines?

A low ROCE (Return on Capital Employed) can indicate that Revolution Medicines has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Revolution Medicines impact the company?

An increase in the ROCE of Revolution Medicines can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Revolution Medicines affect the company?

A decrease in ROCE of Revolution Medicines can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Revolution Medicines?

Some factors that can affect Revolution Medicines's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Revolution Medicines so important for investors?

The ROCE of Revolution Medicines is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Revolution Medicines take to improve the ROCE?

To improve the ROCE, Revolution Medicines can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Revolution Medicines pay?

Over the past 12 months, Revolution Medicines paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Revolution Medicines is expected to pay a dividend of 0 USD.

What is the dividend yield of Revolution Medicines?

The current dividend yield of Revolution Medicines is .

When does Revolution Medicines pay dividends?

Revolution Medicines pays a quarterly dividend. This is distributed in the months of .

How secure is the dividend of Revolution Medicines?

Revolution Medicines paid dividends every year for the past 0 years.

What is the dividend of Revolution Medicines?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Revolution Medicines located?

Revolution Medicines is assigned to the 'Health' sector.

Wann musste ich die Aktien von Revolution Medicines kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Revolution Medicines from 10/31/2025 amounting to 0 USD, you needed to have the stock in your portfolio before the ex-date on 10/31/2025.

When did Revolution Medicines pay the last dividend?

The last dividend was paid out on 10/31/2025.

What was the dividend of Revolution Medicines in the year 2024?

In the year 2024, Revolution Medicines distributed 0 USD as dividends.

In which currency does Revolution Medicines pay out the dividend?

The dividends of Revolution Medicines are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Revolution Medicines

Our stock analysis for Revolution Medicines Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Revolution Medicines Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.